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Abstract 
 
The control of renal vascular tone is important for the regulation of salt and water balance, 
blood pressure and the protection against damaging elevated glomerular pressure. The K+ 
conductance is a major factor in the regulation of the membrane potential (Vm) in vascular 
smooth muscle (VSMC) and endothelial cells (EC). The vascular tone is controlled by Vm via 
its effect on the opening probability of voltage operated Ca2+channels (VOCC) in VSMC. 
When K+ conductance increases Vm becomes more negative and vasodilation follows, while 
deactivation of K+ channels leads to depolarization and vasoconstriction. K+ channels in EC 
indirectly participate in the control of vascular tone by endothelium derived vasodilation. 
Therefore, by regulating the tone of renal resistance vessels, K+ channels have a potential role 
in the control of fluid homeostasis and blood pressure as well as in the protection of the renal 
parenchyma. The main classes of K+ channels (calcium activated (KCa), inward rectifier (Kir), 
voltage activated (Kv) and ATP sensitive (KATP)) have been found in the renal vessels. In this 
review, we summarize results available in the literature and our own studies in the field. We 
compare the ambiguous in vitro and in vivo results. We discuss the role of single types of K+ 
channels and the integrated function of several classes. We also deal with the possible role of 
renal vascular K+ channels in the pathophysiology of hypertension, diabetes mellitus and 
sepsis.  
 
Keywords: vasodilation, vasoconstriction, afferent arteriole, in vivo, in vitro, RVR, RBF  
 
1. Introduction  
 The control of renal vascular tone has a dual purpose. Firstly, it participates in the 
regulation of renal blood flow (RBF) and glomerular filtration rate (GFR). Since the renal 
excretion of Na+ and water is controlled by GFR and tubular reabsorption, the renal vascular 
tone is crucial for the maintenance and regulation of body fluid volume and blood pressure. 
Secondly, it has a protective function by governing intra-glomerular pressure. The 
importance of this function is illustrated by the renal microvascular and glomerular damage 
in several diseases among them hypertension and diabetes 1, 2. Thus, impaired renal vascular 
control could lead to rapid deterioration of arteriolar and glomerular tissue and decreased 
renal function eventually causing renal failure.  
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As in other vascular beds, the constriction of renal vascular smooth muscle cells (VSMC) is 
controlled by the intracellular Ca2+ concentration ([Ca2+]i) in parallel with  Ca2+ independent 
mechanisms 3. VSMC [Ca2+]i is in turn determined by a balance between release and uptake 
from and to intracellular stores (e.g. the sarcoplasmatic reticulum) combined with entry from 
and efflux to the extracellular space.  
Although Ca2+ entry via voltage independent Ca2+ channels may play a role in the regulation 
of renal vascular tone, the entry largely occurs via voltage-operated Ca2+ channels (VOCC) 4, 
5
. These channels are activated by depolarization of the VSMC cell membrane and are thus 
under control of the cell membrane potential (Vm). The dominating VOCC in most vascular 
beds, among them renal, is the dihydropyridine sensitive L-type channel (CaV1.2) 3, 6, 7. 
Furthermore, T-type channels have been found in several vascular beds including renal pre- 
and postglomerular arterioles 7-10 but their role is debated and remains to be fully elucidated 8, 
11-13
. As renal VSMC Vm is mainly determined by K+ channels in these cells, they may have 
an important impact on the salt and water balance and thus blood pressure. There are four 
main classes of vascular K+ channels: calcium activated (KCa), inward rectifier (Kir), voltage 
activated (Kv), and ATP sensitive (KATP). The K2P channels are also found in the vasculature 
but their role is less explored 14. Vm is determined by the ion gradients and their relative 
conductances over the VSMC membrane. In addition, endothelial cells may affect VSMC Vm 
via myoendothelial gap junctions 15. Primarily, it is the intra- and extracellular concentrations 
of K+, Na+ and Cl- ions and their membrane conductances that control Vm. Thus, Vm can be 
derived from the chord conductance equation:   
  
Here Ex is the equilibrium potential for the specific ion x and gx is its conductance. E for the 
ion is calculated by the Nernst equation (here adjusted for body temperature, 37° C, and 
converted to log10): 
 
z is the valence of the particular ion.  
 
Eion ≈ 
[ion]out 
[ion]in log
61.5 mV 
z 
Vm =  
ECl gCl  EK gK +  ENa gNa +  
gK +  gNa +  gCl  
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Significant changes in Vm involve changes in conductances of K+, Na+ and /or Cl- ions. As K+ 
channels are the dominant cation channels in VSMC 16 Vm is largely determined by EK. With 
normal extra- and intracellular concentrations of K+,, calculated as above EK is ~ - 90 mV. 
Owing to the effect of the other ions involved, Vm is more positive. Accordingly, Vm of 
afferent arteriolar VSMC has been found to be between -55 and -40 mV at normal blood 
pressure ranges measured in hydronephrotic kidneys 17-19. Membrane potentials in this range 
are close to the L-type Ca2+ channel activation potential but more positive than that for T-
type Ca2+ channels 19, 20.  
Changes in gK thus affect the tone of the renal vessels. A decreased general K+ conductance 
depolarizes the cell membrane inducing vasoconstriction. An increased K+ conductance has 
the opposite effect 21, 22. In this review, we summarize the current literature on the role of K+ 
channels in the renal vasculature. We deal with studies investigating the integrated renal 
vascular bed as well as in vitro results originating from intra-renal arteries and arterioles. In 
addition, we discuss the possible interaction between several classes of K+ channels in the 
control of renal vascular tone as well as the role of K+ channels in the communication 
between endothelial cells (EC) and VSMC. The role of renal vascular K+ channels in 
renovascular pathology is also discussed.    
 
Renal vascular K+ channels 
The nomenclature for vascular K+ channels used in this review is based on the International 
Union of Basic and Clinical Pharmacology (IUPHAR). Table 1 provides a comparison 
between the IUPHAR classification and the colloquial names for channels dealt with in this 
review. The K+ channels are distributed into four subfamilies: 1. Calcium activated (KCa), 2. 
Inwardly rectifying (Kir), 3. Voltage gated (KV), 4. Two-pore domain (K2P) channels.  
Based on their permeability, KCa channels are further subdivided into large, intermediate and 
small conductance calcium-activated potassium channels (BKCa, IKCa and SKCa, respectively). 
The KATP channels are composed of Kir6.1 or Kir6.2 subunits and thus they belong to the 
inward rectifier super family 23. To our knowledge, the possible significance of K2P channels 
in the renal vasculature has never been investigated.  However, considering the diversity of 
K+ channels, it is highly possible that classes of K+ channels which have not yet been 
described in the renal vasculature participate in the regulation of renal hemodynamics 24. 
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K+ channels in renal vascular smooth muscle 
BKCa channels in VSMC 
The conductance of BKCa channels is in the range of 100-200 pS 25-27. In addition to their 
Ca2+- sensitivity, they are also sensitive to electrical potential 25. At negative membrane 
potentials (-50 to -70 mV) close to normal resting potentials measured in vivo in VSMC 28, 
activation is reported to require intracellular [Ca2+] in the range of 1-10 µM 29, 30. Therefore, 
it is not totally clarified to what extent BKCa channels contribute to the normal resting Vm 29. 
Physiologically, BKCa may be modulated by protein kinases. Although there are a few 
exceptions 31, most reports indicate that they are activated by protein kinase A 32 and/or G 33, 
34
 (PKA and PKG, respectively; Fig. 2) and inhibited by protein kinase C (PKC; Fig. 1) 35, 36. 
Nitric oxide (NO) stimulates the PKG pathway. Therefore activation of the NO system 
potentially may lead to increased activity of BKCa channels (Fig. 2) 37. Likewise, it is 
suggested that vasoconstrictors could act via PKC mediated inhibition of BKCa channels (Fig. 
1) 35, 36. BKCa channels are pharmacologically inhibited by tetraethylammonium (TEA), 
charybdotoxin or more specifically by iberiotoxin.  They are stimulated by NS 1619 38.  
Function 
BKCa channels may have a buffering function on vasoconstrictor responses (Fig. 1) 39. The 
depolarization and increase in VSMC [Ca2+]i, resulting from agonist stimulation or myogenic 
activation activates BKCa channels, initiating a hyperpolarizing current that  attenuates 
depolarization and opposes vasoconstriction 40. There is evidence that a complex formed by 
BKCa channels and VOCC might provide a basis for the control of BKCa channel activation 41. 
Accordingly, in several vascular beds it is shown that BKCa channels open simultaneously 
with the L-type Ca2+ channels 29, 42. Furthermore, ryanodine-sensitive Ca2+
 
release from 
intracellular stores may also buffer vasoconstriction via BKCa channel activation 43.  
Renal function 
We and others have found evidence for the expression of BKCa channels in rat preglomerular 
vessels utilizing RT-PCR and immunofluorescence 44, 45. Their presence has also been 
suggested in rat mesangial cells and an iberiotoxin sensitive current has been identified in rat 
juxtaglomerular cells 45 46, 47.  
TEA is reported to induce an elevated basal perfusion pressure in the isolated perfused rat 
kidney which suggests that BKCa channels contribute to the basal renal vascular tone. 48, 49. 
These results should be interpreted with caution as the TEA concentration used in these 
studies were between 2 and 10 mM, concentrations where TEA is not specific for the BKCa 
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channel but is reported to also inhibit both Kv channels and KATP channels 50, 51. Nevertheless, 
a lower concentration of TEA (1mM) has been reported to constrict the afferent arteriole 
using the blood perfused juxtamedullary nephron preparation 52, 53. Using the same technique 
it was shown that stimulation with the BKCa channel opener NS 1619 (30 µM) increased 
afferent arteriolar diameter, an effect that was abolished by TEA (1mM) 54. At these 
concentrations the authors assumed NS 1619 and TEA to be specific for the BKCa channels. It 
should, however, be kept in mind that even at these concentrations NS 1619 and TEA has 
been shown to affect KV channels 55-58. We found that TEA, at an estimated plasma 
concentration of 1 mM infused directly into the rat renal artery in vivo reduced baseline RBF 
by ~10 %. Meanwhile the more specific BKCa channel blocker  iberiotoxin, at an estimated 
plasma concentration of 100 nM, had no effect 44. Furthermore, we found that NS 1619 
(estimated plasma concentration 30 µM) had no effect on rat RBF in vivo 44. These results 
indicate a limited role for BKCa channels in the regulation of renal vascular tone under resting 
conditions in vivo and are in contrast to the in vitro results emanating from the blood perfused 
juxtamedullary nephron preparation. The discrepancy between the in vivo and the in vitro 
studies might be explained by different [Ca2+]i or Ca2+ -sensitivity. The effect of NS 1619 is 
Ca2+ dependent and it is possible that in vivo [Ca2+]i in renal VSMC is not sufficient to allow 
activation by NS1619 38.Thus, it is unclear whether BKCa channels have a role in the 
maintenance of the normal resting potential of renal VSMC and therefore in renal vascular 
tone. 
Renal buffer function 
As in Fallet et al. 54, we found that renal vasoconstriction induced by Ang II in vivo was 
impaired by NS 1619 44. The effect was reversed by TEA and iberiotoxin indicating that the 
attenuation is caused by stimulation of BKCa channels. Possibly the elevated [Ca2+]i under 
Ang II stimulation facilitates the action of NS 1619. The attenuating effect of NS 1619 on the 
ANG II responses indicates that the renal BKCa channels may have a buffering function on 
vasoconstrictor responses (Fig. 1). The activation of BKCa channels may also play a role in 
renal vasodilation. However, TEA and iberiotoxin did not augment the juxtamedullary 
afferent arteriolar diameter reduction in vitro or in vivo in response to vasoconstrictors 44, 54. 
On the other hand Loutzenhiser & Parker found that TEA elevated myogenic response of 
afferent arterioles which indicates that renal myogenic vasoconstriction might be buffered by 
opening of  BKCa channels 59.  
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Activation of adenylate or guanylate cyclase and subsequent increases in cAMP or cGMP, 
respectively, followed by increased kinase activity may induce activation of BKCa channels 
and vasodilation 33, 60. We did not find support in vivo for cAMP stimulation of BKCa 
channels leading to vasodilation. Renal vasodilation induced by forskolin, an activator of 
adenylate cyclase, was not affected by iberiotoxin in rats 44. However, cAMP stimulates 
several other K+ -channels. We cannot exclude the possibility that the vasodilation was 
caused by activation of several classes of these channels, including BKCa channels.  
BKCa channel β-subunits contribute to a large diversity in BKCa channel function. Mice 
lacking the subunit Mbeta1 are mildly hypertensive. During acute volume expansion, the 
increase in GFR seen in wild type mice was decreased in the Mbeta1-/- mice indicating a role 
for the beta1-subunit of BKCa channels in the renal vasodilatory response to acute volume 
loading 61 62.  
NO causes renal vasodilation and based on studies on isolated VSMC from rat preglomerular 
vessels, it is suggested that activation of BKCa channels may be involved. It was shown that 
the NO donor sodium nitroprusside reduced the increase in [Ca2+]i in response to 50 mM KCl 
and that iberiotoxin reestablished this response 63. This suggests a role for BKCa channels in 
NO induced renal vasodilation. On the other hand, it is somewhat challenging to comprehend 
how activation of BKCa channels would cause sufficient hyperpolarization to inactivate 
VOCC in the presence of 50 mM KCl. Nernst´s equation show that EK in this condition is 
much more positive than the activation level of L-type VOCC. As opening of BKCa channels 
would not cause Vm to become more negative than EK, a substantial effect on VOCC activity 
cannot be predicted. In addition, TEA has only a slight effect on the afferent arteriolar 
vasodilation in response to acetylcholin (ACh) as shown in the perfused hydronephrotic rat 
kidney 64. This finding does not support a BKCa channel mediated NO induced renal 
vasodilation as the ACh response is largely mediated by NO 64-66. On the other hand, BKCa 
channels may mediate the effect of other vasodilators. Epoxyeicosatrienoic acid (EET), 
which has been suggested to participate in endothelial derived hyperpolarization (EDH), 
causes afferent arteriolar vasodilation that is inhibited by iberiotoxin, indicating a role for 
BKCa channels in this setting 67 (Fig. 2). It has also been suggested that EETs may mediate 
the afferent arteriolar vasodilation induced by bradykinin via activation of BKCa channels 68.  
In summary, renal BKCa channels do not seem to affect renal vascular resistance in vivo even 
though in vitro results suggests this. BKCa channels do however seem to act as buffers in 
response to agonist- or pressure induced vasoconstriction. 
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IKCa and SKCa channels in VSMC 
Only few studies suggest the presence of IKCa and SKCa channels in renal VSMC. One study 
shows the presence of an apamin-sensitiv K+ channel with a conductance of 68 pS in VSMC 
isolated from preglomerular arterioles 69. However, functional evidence for a role in 
regulation of renal blood flow is lacking. In the isolated blood perfused juxtamedullary 
nephron preparation no change in afferent arteriolar diameter was seen after treatment with 
100 nM apamin 52 and intrarenal infusion of apamin (0.5 µM) had no effect on RBF in vivo 
10
. 
 
Kir channels in VSMC 
The single channel conductance of the classic Kir channel (Kir2) is ~ 20 pS 16. In the vascular 
system, Kir channels predominantly reside in VSMC from microvessels where the main 
isoform is Kir 2.1 70-73. They are named “inward rectifier” channels since they carry larger 
inward (at potentials negative to EK) than outward currents Kir (Fig. 3). As Vm is more 
positive than EK under physiological conditions, Kir channels carry a small outward 
hyperpolarizing K+ current 74. This current is sensitive to extracellular K+ concentration 
([K+]o) 75. A small increase (~5 – 12 mM) in [K+]o increases the outward current at membrane 
potentials measured in afferent arteriolar VSMC 17 (Fig. 3). The mechanism might be 
mediated by interaction of K+ ions with polyamines or Mg2+ in the channel pore causing 
increased opening probability 76, 77. When [K+]o is increased to > ~20mM, the depolarizing 
effect of the increased [K+]o, according to the Nernst equation, becomes dominant and the net 
effect is depolarization. Kir channels may also function as an amplifier of hyperpolarization if 
Vm becomes more hyperpolarized and thus reaches a voltage range with larger conductance 
and thus elevated outward current 78-81. At concentrations lower than 100 µM, Ba2+ is 
considered to be specific for Kir channels with a reported half maximal inhibition 
concentration of 2.2 µM at -60 mV 82.  
Function 
As Kir channels are sensitive to small elevations in [K+]o, they may participate in K+  induced 
vasodilation as a part of the metabolic regulation of blood flow 83-85. Furthermore, they may 
have a role in the EDH response via K+ released from endothelial IKCa and SKCa channels 
(Fig. 2) 86. It is possible that part of the K+ induced hyperpolarization/vasodilation is 
mediated by activation of Na/K ATPase 87.  
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Renal function 
In the renal vasculature, Kir2.1 channels are expressed in both VSMC and EC of rat afferent 
and efferent arterioles 88, 89. In the rat descending vasa recta, both the endothelial cells and the 
pericytes express Kir2.1, Kir2.2, and Kir2.3 channels 90, 91. Kir currents have been identified in 
the afferent and efferent arterioles and the distal rat interlobular artery (ILA) while they are 
absent in the proximal part of the same vessel 90, 92-94.  
At concentrations supposed to be specific for Kir channels (≤ 100 µM), Ba2+ reduced afferent 
arteriolar diameter 18. Likewise renal vascular resistance (RVR) was increased in isolated 
perfused kidneys after Ba2+ treatment 48. We found that infusion of Ba2+ into the rat renal 
artery, at an estimated final plasma concentration of 20 µM, caused a small (6–13%) transient 
elevation of baseline RVR in vivo 89. These studies indicate a role for Kir channels in the 
basal RVR. 
K+ induced renal vasodilation 
An increase in plasma [K+] has been reported to decrease RVR, increase GFR, urine flow and 
Na+ excretion in several species 95-97, 98. These findings are in accord with the notion of a K+ 
induced renal vasodilation 97. It is possible that such a mechanism is relevant when plasma K+ 
increases following metabolic stress where K+ induced renal vasodilation may have a 
protective function. As high dietary K+ is correlated with a decreased risk for cardiovascular 
disease it may also be speculated that the slightly increased plasma [K+] that follows high K+ 
intake mediates renal vasodilation and decreased arterial blood pressure via stimulation of 
renal vascular Kir channels 97, 99. In this regard it is interesting that small physiologic changes 
in K+ concentration have been reported to participate in the control of renal medullary blood 
flow via Kir channels located in vasa recta 90, 91.  
The K+ induced renal vasodilation may be caused by activation of either Na+/K+ -ATPase or 
Kir channels with subsequent VSMC hyperpolarization 18, 88, 100. K+ induced vasodilation of 
afferent arterioles was blocked by Ba2+ 18, 88. In the larger rabbit, arcuate artery vasodilation 
was blocked by ouabain, an inhibitor of the Na+/K+ -ATPase 100. This is in line with the 
notion of a more pronounced activity for Kir channels in smaller vessels. Chilton et al. have 
shown that the K+ induced vasodilation of the interlobular artery was correlated to vessel 
diameter 92. The distal interlobular artery (ILA) dilated in response to 15 mM K+ while this 
response was absent in the proximal ILA. The response was inhibited by 100 µM Ba2+ but 
not by ouabain 92. Different results might be obtained when the integrated response of the 
intact renal circulation is under investigation. Accordingly, in isolated perfused rat kidneys, 
Ba2+ or ouabain attenuated the K+ induced renal vasodilation. This indicates a role for both 
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Kir channels and Na/K ATPase in this process 97. Our laboratory has confirmed this in vivo in 
normotensive rats while the effect of ouabain was not significant in hypertensive rats 89.  
 
Voltage-gated K+ channels in VSMC 
Voltage-gated K+ (KV) channels exhibit conductances between ~4 and 70 pS depending on 
subtype, preparation and experimental conditions 16, 101-104. They are strongly voltage 
dependent and cell membrane depolarization leads to activation of KV channels (Fig. 1) and 
thus an increased hyperpolarizing outward K+ current that deactivates VOCC channels and 
consequently decreases VSMC tone 16, 39, 85, 105 (Fig. 2).  
Function 
KV channels may contribute to the regulation of resting membrane potential by buffering 
membrane depolarization to maintain resting vascular tone 39. In addition to the classical 4-
aminopyridine (4-AP) sensitive KV 1.1 - 1.7 channels, KV7 channels have recently been 
described in VSMC from several vascular beds among them renal 106-112. Prolonged 
depolarization leads to inactivation of KV channels which is a slower process than that of 
activation. Thus, the steady state current via these channels is determined by the balance 
between activation and inactivation 16, 34, 39, 113, 114. Like other K+ channels, KV1.x channels 
are activated by the cAMP/PKA and cGMP/PKG pathway115, 116 (Fig. 2) and the activity is 
reduced by PKC (Fig. 1) 36, 117-120. Specifically, it is reported that PKA increases open 
probability of 4-AP sensitive single channels 119. 
In contrast to the 4-AP sensitive channels which are activated at –20 mV, the KV7 channels, 
which are insensitive to 4-AP, activate at a more negative membrane potential. This potential 
is in the range of the resting membrane potential of renal arteriolar VSMC (-60 mV to -40 
mV) 17, 121, 122. It is therefore likely that the physiological role of KV7 channels is different 
from that of the 4-AP sensitive KV channels. KV7 channels could have a larger impact on 
normal resting potential while KV1 channels may exhibit more of a buffering function 85, 122. 
KV7.x channels are pharmacologically inhibited by XE991 or linordipine and KV7.2-5 
channels are stimulated by flupirtine or retigabine 122, 123.  
Renal function 
We and others have identified the expression of Kv1.2 and Kv1.4 channels in rat interlobar 
and arcuate arteries 124 and KV1.4 channels in rat and mice afferent arteriolar VSMC 10. 
Using patch clamp, 4-AP sensitive currents have been detected in VSMC from rat renal 
arcuate and interlobar arteries 114, 125. However, in rabbit arcuate arteries KV channels did not 
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participate in maintenance of normal tone but seemed to have a buffering effect against 
depolarization in these vessels 126. An intermediate conductance K+ current sensitive to 4-AP 
has been reported in VSMC from rat preglomerular vessels 127. Furthermore, a functional role 
for 4-AP sensitive KV channels has been suggested based on studies in the blood perfused 
juxtamedullary nephron preparation 52 or the isolated perfused rat kidney 48. In both these 
studies, 4-AP induced renal vasoconstriction.  
KV7 channels have been found in the rat renal artery and in the isolated perfused rat kidney 
112
. In that study it was found that linopirdine contracted isolated rat renal arteries. This is in 
accord with a recent report from our laboratory 111. Using imunofluorescence, we revealed 
the expression of KV7.4 channels in rat afferent arterioles. Our results also pointed to a role 
for these channels in the maintenance of basal RVR. Namely, intrarenal XE991administration 
led to a reduction of rat RBF in vivo as well as a reduction in mouse afferent arteriolar 
diameter as assessed by the blood perfused juxtamedullary nephron technique. These effects 
were abolished by nifedipine indicating that inhibition of KV7 channels led to depolarization 
and activation of L-type Ca2+ channels. In addition flupirtine caused relaxation of isolated rat 
interlobar arteries in the wire myograph as well as an increase of RBF in vivo. In chronically 
instrumented conscious rats, retigabine caused transient renal vasodilatation in normotensive 
rats. This effect was augmented after Ang II induced acute hypertension 128. These findings 
suggest a therapeutic potential for KV7 channel stimulation in the treatment of unfavorable 
renal vasoconstriction in vascular disease states. 
 
Renal buffer function 
In addition to contributing to the basal renal tone, it was found that KV7 channels partly 
mediate β-adrenoceptor–mediated renal vasodilation 112. Furthermore, the RBF responses to 
the renal vasoconstrictors NE or Ang II were not affected by pretreatment with XE991 or 
flupirtine 111. Surprisingly, XE991 pretreatment caused a minor augmentation of the ACh 
induced increase in RBF. Thus, KV7 channels do not seem to mediate or buffer agonist 
induced renal vasoconstriction or vasodilation. 
 
ATP-sensitive K+ channels in VSMC 
The ATP-sensitive K+ channel (KATP) comprises four transmembrane domains emanating 
from the Kir channel family (Kir6.1 or Kir6.2; table 1) which forms the pore, and four 
additional subunits of sulfonylurea receptors (SUR1, SUR2A and SUR2B) exhibiting a 
regulatory function 23. The single channel conductance for KATP channels shows a substantial 
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variation between different tissues as values from 15 pS to 258 pS have been reported for 
VSMC 23, 39, 129. These channels are inhibited physiologically by elevated intracellular ATP 
(Fig. 1) and stimulated by ADP 39. As the ATP/ADP ratio regulates their activity, they have 
the potential to adapt the vascular tone to the metabolic needs of the tissue 130. In addition, 
they are stimulated by PKA (Fig. 2) and/or PKG and inhibited by PKC 16, 85. 
Pharmacologically, they are inhibited by sulfonylureas such as glibenclamide and stimulated 
by drugs such as cromakalim, pinacidil and diazoxide 131.  
Renal function 
Lorenz et al. found a K+ channel in rabbit afferent arteriolar myocytes with an unusually high 
conductance (258 pS) which was inactivated by 1 mM ATP 129. The authors also reported that 
the KATP channel opener diazoxide dilated rabbit isolated afferent arterioles in vitro while 
these vessels were constricted by the KATP channel inhibitor glibenclamide 129. Binding 
studies and in situ hybridization histochemistry have revealed the existence of KATP channels 
in smaller rat renal arteries and arterioles 132. 
Jensen et al. found in the isolated perfused rat kidney that cromakalim caused a renal 
vasodilation that was attenuated by glibenclamide 133. It has also been shown, using the 
blood-perfused juxtamedullary nephron preparation, that pinacidil caused afferent arteriolar 
vasodilation whereas glibenclamide had little effect on afferent arteriolar tone 134.  
Several in vivo studies have found that different KATP channel stimulators increase RBF in 
rats and dogs 135-139 whereas glibenclamide had no effect on RBF in rats 10.    
KATP channels and glibenclamide sensitive currents has also been described in the rat 
descending vasa recta 140.  
Metabolic vasodilation 
Lowered glucose concentrations led to vasodilation in isolated rabbit afferent arterioles, an 
effect that was reversed by glibenclamide. This supports the notion of regulation of renal 
blood flow by intracellular levels of ATP 129. Furthermore, glibenclamide constricted while 
pinacidil dilated afferent arterioles from rats with streptozotocin-induced diabetes implicating 
KATP channels in the hyperfiltration seen in diabetes 134.  
It has also been suggested that KATP channels mediate the vasomotor response to changes in 
oxygen tension in different vascular beds 21, 130. The rat afferent arteriolar myogenic response 
was attenuated via activation of KATP by low oxygen tension (PO2 20 mm Hg). This 
myogenic response was restored by glibenclamide 59. These findings suggest that KATP 
channels have a function in the adaptation of renal perfusion to hypoxia. As the cortex 
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normally has a low arterio-venous PO2 difference, one could speculate that this mechanism is 
more important in the medullary circulation with its lower oxygen tension. 
Based on results obtained in the perfused hydronephrotic rat kidney, it is suggested that 
afferent arteriolar vasodilation induced by calcitonin gene-related peptide (CGRP) or 
activation of A2a adenosine receptors is mediated via activation of KATP channels 141, 142.  
 
K+ channels in renal endothelium 
BKCa channels in EC 
BKCa channels are present in endothelial cell of some vascular beds 143, 144. Hyperpolarization 
of EC following activation of BKCa channels can increase the electrochemical gradient for 
Ca2+ thus increasing the Ca2+  influx to modulate NO production 144-146. In addition, release of 
K+ from endothelial BKCa channels have been suggested to function as an endothelial derived 
hyperpolarizing factor (EDHF) by activation of KIR channels or Na+/K+-ATPases on VSMC 
86, 147
. 
BKCa channels in renal EC 
BKCa channels have been identified in EC from renal arteries 145 whereas expression in EC 
from smaller arteries was not confirmed 44. A functional role in regulation of renal 
hemodynamics has not been shown. 
 
SKCa and IKCa channels in EC 
Small conductance potassium channels (SKCa) and intermediate conductance potassium 
channels (IKCa) have been found in most endothelial cells in the vasculature including the 
renal vasculature. The IKCa and SKCa channels are activated by increased [Ca2+]i within the 
physiological range and they are not voltage sensitive 148. The SKCa and IKCa channels have 
conductances of 10 pS and 40 pS, respectively 149, 150. SKCa channels are inhibited by apamin 
and the IK channels by TRAM-34 and the less specific charybdotoxin 144, 146. Both IKCa and 
SKCa channels are stimulated by NS 309 151. 
IKCa channels are mostly located in the vicinity of myoendothelial junctions (MEJ) whereas 
the SKCa channels are distributed more evenly over the endothelial surface 152-154. However, 
this distribution remains to be quantified in renal arteries and arterioles.  
In endothelial cells, activation of IKCa and SKCa channel by Ca2+  involves activation of a G-
coupled receptor and an IP3 mediated increase in cytosolic Ca2+ 155. [Ca2+]i can also be 
modulated by the opening of endothelial TRP channels 146, 156. TRP channel activity has 
directly been linked to IKCa opening in the MEJ 157. It is suggested that the location of IKCa 
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channels in the MEJ creates a signaling micro-domain that allows Ca2+ to be elevated only in 
the MEJ and thereby specifically activate the IKCa channels here 158, 159. 
SKCa and IKCa  channels in renal EC 
Endothelial IKCa and SKCa channels are expressed in the renal vasculature 10, 69. Apamin-
induced inhibition of SKCa channels increases RVR in the isolated perfused kidney 48. In 
contrast, it does not affect baseline rat afferent arteriolar diameter in the blood-perfused 
juxtamedullary model 52 or RBF in anesthetized rats 10.  
Renal EDH 
Endothelium derived hyperpolarization (EDH) is defined as the endothelial mediated 
vasodilation elicited by ACh or bradykinin that remains when NO and prostacyclin 
production is inhibited 160. The current generated by the activation of IKCa and SKCa channels 
is suggested to initiate a hyperpolarizing current into the VSMC via MEGJ. Furthermore, 
IKCa and SKCa channel activation may increase the K+ concentration in the extracellular space 
between EC and VSMC. This in turn leads to activation of VSMC Kir channels and Na+/K+-
ATPases and to hyperpolarization of these cells 15, 86, 161-163. The exact mechanisms behind 
EDH remain unclear and may depend on the vascular bed and the arterial segment 160, 164-166. 
This might explain some of the different results that have been obtained in vitro with renal 
arteries and arterioles 43, 61, 137, 167. Some have shown a major role of IKCa and SKCa channels 
in renal EDH whereas others have suggested a minor role. Boettcher et al 168 showed that in 
a. gracilis under isometric conditions lack of connexin 40 reduced the EDH response whereas 
under isobaric conditions the EDH response was unaffected. This difference between isobaric 
and isometric setups might also provide an explanation for the discrepancy.  
In the renal vasculature, in vitro studies have shown that the EDH-response can be abolished 
by co-treatment with apamin and charybdotoxin 64, 163, 169. In the hydronephrotic rat kidney, 
Wang et al showed that inhibition of either the IKCa or SKCa channel with charybdotoxin or 
apamin respectively reduced the EDH response and a combination abolished the EDH 
response 64, 68. Under isometric conditions, we found that the EDH mediated vasodilation in 
rat renal interlobar arteries was inhibited by a combination of TRAM-34 and apamin. Also, 
inhibition of Na+/K+-ATPase and Kir channels reduced the magnitude of EDH 15.  
In vivo, the renal EDH is commonly quantified as changes in RBF. In wistar rats renal EDH 
was reduced when the IKCa and SKCa channels were inhibited with charybdotoxin and apamin 
170
. In Sprague-Dawley rats we found that the EDH response was absent when inhibiting the 
IKCa and SKCa channels with a combination of TRAM-34 and apamin 15. This suggests that 
IKCa and SKCa channels are crucial for renal EDH, but that the complete mechanism is not 
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clarified 15. In contrast to the in vitro results, we found in vivo that inhibition of Na+/K+-
ATPase and Kir channels did not reduce the magnitude of EDH 15.  
 
Kir channels in EC 
Kir channels are also found in EC 171 where Kir2.1 seems to be the dominating isoform 172. In 
renal vessels, Kir is found in EC in afferent and efferent arterioles 88, 89, in the renin-secreting 
cells 94 and in the EC and pericytes of the decending vasa recta 90, 91. Inhibition of renal Kir 
channels induce vasoconstriction both in vitro 18, 48 and in vivo 89 but whether this is caused 
by Kir channels expressed in EC or VSMC is hard to distinguish. In small mesenteric arteries, 
only EC express Kir and inhibition of these significantly reduces vasodilation in response to 
ACh 173 and flow-induced vasodilation 174. 
 
KV and KATP channels in EC 
Although both KV and KATP channels have been shown in EC, their exact role in regulation of 
renal vascular tone has not yet been clarified. 
 
Renal vascular K+ channels in integrated renal hemodynamics.  
Several blockers of K+ channels have a constrictor effect on renal vessels in vitro 48 and in 
vivo 10, 89. Specifically BKCa, Kir, KV1, KV7 and KATP channels have been shown to affect 
baseline renal vascular resistance in vitro whereas Kir, KV7 and KATP affect RBF in vivo. 
However, the constrictor effect seems to be additive as blockage of a single group of 
channels elicits a smaller change than inhibition of several channels 10, 48 suggesting a 
considerable overlap in function. Closure of the K+ channels causes depolarization of VSMC 
and opening of VOCC followed by vasoconstriction. Conversely, opening of K+ channels 
leads to hyperpolarization and renal vasodilation. However, adding individual stimulators as 
well as a cocktail of K+ channel openers in vivo only elicits minor effects on basal RBF, 
while the same cocktail attenuated the RBF responses to AngII and norepinephrine by 60 % 
and 33 %, respectively 10. 
In the kidney, BKCa channels in VSMC has been proposed to function as a buffer during 
agonist induced vasoconstriction 27, 35, 36, 85, 126 (Fig. 1). In addition, the BKCa channel opener 
NS 1619 attenuated Ang II induced reductions of RBF in vivo and this effect was reversed by 
iberiotoxin 44. BKCa channels also act as a buffer during the renal myogenic response 59. 
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As in other vascular beds, SKCa and IKCa channels in renal EC are suggested to induce 
endothelial derived hyperpolarization. This hyperpolarization can transfer to VSMC via 
myoendothelial gap junction. Furthermore,, the K+ released from EC via SKCa and IKCa 
channels can active KIR channels and Na+/K+-ATPases on VSMC to induce 
hyperpolarization and renal vasodilation. Renal KIR channels also play a role in K+ induced 
vasodilation to elicit increases in RBF, GFR and sodium excretion possibly reducing arterial 
blood pressure during high potassium intake 99. 
Renal vessels express both KV1 and KV7 channels and KV7 are suggested to mediate β-
adrenergic renal vasodilation. 
Inactivation of several classes of K+ channels might be mediated by PKC induced 
phosphorylation 16, 36, 85, 175. Blockade of PKC attenuates the Ang II or norepinephrine 
induced increase in afferent arteriolar VSMC [Ca2+]i 176 suggesting that activation of PKC 
leads to depolarization via inhibition of K+ channels 4. In addition, renal afferent arteriolar 
myogenic activity is attenuated by PKC inhibition 177. This effect was reversed by 4-AP 
suggesting that PKC has an inhibitory effect on KV channels (Fig. 1). As PKC inhibits 
several other classes of K+ channels, it is likely that K+ channels other than KV channels are 
involved in this response 16, 85.  
 
Renal vascular K+ channels in disease. 
Hypertension 
K+ channel function is altered in hypertension 178. However, the manner of alteration 
may differ between channels. While KATP and Kir channel function is supposed to be reduced 
in hypertension, BKCa channel function is up-regulated 16, 178, 179. IKCa channel expression is 
also up-regulated during hypertension 180. On the other hand, other authors reported a reduced 
expression of both SKCa and IKCa channels during Ang II-induced hypertension 181. Likewise 
our laboratory has found that mRNA of SKCa and IKCa channels were significantly down-
regulated in obese fructose/fat fed rats with elevated blood pressure 182. Regarding the renal 
vascular system, information is scarce. Comparing VSMC from renal interlobar arteries from 
WKY, SD, SHR and DOCA rats Martens and Gelband found an upregulation in KV channels 
activity and a down-regulation in KCa channel activity 183. It has also been reported that KATP 
channel function is down-regulated in hypertension 139, 184. Activation of BKCa in renal 
arteries from SHR was reduced compared to WKY possibly caused by a decrease in NO 
production 185. Furthermore, expression of KV7.4 in renal arteries from SHR is significantly 
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reduced 112. However, there is an urgent need for studies dealing with altered renal vascular 
K+ channels function in different forms of hypertension.  
 
Diabetes 
In diabetes mellitus (DM), elevated KATP and Kir channel function may contribute to 
preglomerular vasodilation and hyperfiltration 52, 134, 186. Kir1.1 and/or Kir3.x channels 
contribute to the afferent arteriolar dilation seen in DM 52. The same study showed that the 
effect of TEA on afferent arteriolar diameter was similar in control rats and DM rats 
indicating that BKCa channel function is not altered 52. Also, glibenclamide constricted 
afferent arterioles from rats with DM while the effect was absent in normal rats 134.  
Thus, increased KATP channel function may contribute to the early DM hyperfiltration 186. In 
addition, oxidative stress may contribute to the exaggerated vasodilating actions of Kir1.1, 
Kir2.1, and KATP channels on afferent arteriolar tone during DM 187. On the other hand, using 
clearance methods, Vallon et al. were unable to find any renal vascular effect of the KATP 
channel blocker U37883A in rats with DM 188. It is clear that there is a need for more 
research to fully elucidate a possible role for renal vascular K+ channels in early diabetic 
hyperfiltration. 
 
Sepsis 
Activation of vascular BKCa or KATP channels may be involved in the hypotension associated 
with sepsis 189-192. However, treatment with blockers or lack of these channels has not shown 
any beneficial effects 193-195. Levosimendan, a KATP  channel activator, exhibited protection 
against lipopolysaccharide -induced acute renal failure 189. This is in line with a study 
demonstrating that despite the fact that glibenclamide or iberiotoxin increased blood pressure 
and vascular reactivity to vasoconstrictors in septic animals, the treatment led to a substantial 
reduction in RBF especially after treatment with drugs, such as norepinephrine and 
phenylephrine putting renal perfusion at risk 190.  
 
Concluding remarks 
It is clear that renal vascular K+-channels play a significant role in the regulation of 
renal vascular tone. In the literature, there is a considerable volume of information available 
regarding the role of the individual classes of renal vascular K+-channel in a variety of in 
vitro settings. However, studies characterizing K+ currents in renal resistance vessels are 
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sparse as are studies investigating these channels in in vivo settings. Information regarding 
the role of these channels in different disease conditions is especially scarce. An increased 
knowledge about renal vascular K+-channel function in physiology and during 
pathophysiological conditions such as hypertension, DM and sepsis may increase the 
potential for renoprotection in these conditions.  
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Table legends 
Table 1. The four super families of K+ channels. Shown are the International Union of Basic 
and Clinical Pharmacology (IUPHAR) nomenclature for relevant members expressed in renal 
vascular tissue, the gene names and some of the common aliases. 
Table 1: K+ channels 
 
Family Subtype Renal 
vascular 
members 
Gene name Alias 
Ca2+ activated (KCa) KCa1 KCa1.1 KCNMA1 BKCa or Slo 
 KCa2 KCa2.1-2.3 KCNN1-3 SKCa or SK1-3 
 KCa3 KCa3.1 KCNN4 IKCa 
     
Inwardly rectifying (Kir) Kir1-6 Kir1.1 KCNJ1 ROMK 
  Kir2.1-2.2 KCNJ2/12 Kir 
  Kir6.1-6.2 KCNJ8/11 KATP 
     
Voltage gated (KV) KV1-12 KV1.1-1.8 KCNA1-7; 10 KV Shaker-related 
  KV7.1-7.5 KCNQ1-5 KCNQ 
     
Two-P K2P K2P2.1 KCNK2 TREK-1 
  K2P3.1 KCNK3 TASK-1 
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KCa nomenclature: 196 
Kir nomenclature: 197 
KV channel nomenclature: 198 
K2P nomenclature: 199 
 
Figure legends 
Figure 1. Pathways leading to vasoconstriction via deactivation of K+ channels in vascular 
smooth muscle cells (shown with red arrows). The following depolarization and increase in 
[Ca2+]i can activate K+ channels to buffer the vasoconstriction (shown with green arrows). 
See text for details. Blue arrow = effect; Red arrow = deactivation; Green  arrow = activation. 
VOCC: voltage activated calcium channel, Vm: membrane potential, SR: sarcoplasmatic 
reticulum, PKC: protein kinase C, IP3: inositol trisphosphate, 20-HETE: 20-
Hydroxyeicosatetraenoic Acid 
 
Figure 2. Pathways leading to vasodilation via activation of K+ channels in endothelial cells 
or vascular smooth muscle. See text for details. Blue arrow = effect; Red arrow = inhibition; 
Green  arrow = activation. 
ER: endoplasmatic reticulum, Cyt P450: cytochrome P450, NOS: nitric oxide synthase, Vm: 
membrane potential, EET: Epoxyeicosatrienoic acids, MEGJ: myoendothelial gap junctions, 
K+EC: K+ released from the endothelial cell, cGMP: cyclic GMP, PKG: protein kinase G, 
VOCC: voltage activated calcium channel, PKA: protein kinase A 
 
Figure 3. Current-voltage relationship for Kir channels at three different extracellular K+ 
concentrations. The curves are calculated using the equations for the Kir channel in Edwards 
et al 74. EK used is calculated from the Nernst equation using [K+]out = 5 mM, 12 mM or 20 
mM and [K+]in=130 mM. Vm covers the range of measured values (-55 mV - -40 mV) in 
afferent arteriolar VSMC 17, 121. 
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